FDA Clearance Tracker · P200035-S012
OrganOx metra System
Last checked: Nov 20, 2026Latest source record: Oct 27, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Oct 27, 2023
Approved
Time to decision
29 days
Received Sep 28, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P200035-S012
- Device name
- OrganOx metra System
- Applicant
- Organox Limited
- Applicant location
- Oxford
- Received
- Sep 28, 2023
- Decided
- Oct 27, 2023
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P200035
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for an amendment to the OrganOx metra New Enrollment PAS (P200035/PAS003) protocol to include a study arm with the goal of collecting data on livers from DCD donors older than 40 years of age, perfused with the OrganOx metra and transplanted in adult recipients
Source documents
Other decisions for Organox Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P200035 · Decided Dec 9, 2021 · 512 days after receipt
Device type: Normothermic machine perfusion system for the preservation of donor livers prior to transplantation (QQK) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.